170 related articles for article (PubMed ID: 8689268)
1. The role of calcium-channel antagonists in solid organ transplantation.
Huntress JD; Papadakos PJ
New Horiz; 1996 Feb; 4(1):129-33. PubMed ID: 8689268
[TBL] [Abstract][Full Text] [Related]
2. Nephrotoxicity associated with cyclosporine and FK506.
Klintmalm GB; Gonwa TA
Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):11-9. PubMed ID: 9346596
[TBL] [Abstract][Full Text] [Related]
3. Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations.
Andoh TF; Burdmann EA; Bennett WM
Semin Nephrol; 1997 Jan; 17(1):34-45. PubMed ID: 9000548
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive properties of calcium channel blockers.
Chitwood KK; Heim-Duthoy KL
Pharmacotherapy; 1993; 13(5):447-54. PubMed ID: 8247910
[TBL] [Abstract][Full Text] [Related]
5. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine: advantages versus disadvantages vis-à-vis tacrolimus.
Maes BD; Vanrenterghem YF
Transplant Proc; 2004 Mar; 36(2 Suppl):40S-49S. PubMed ID: 15041305
[TBL] [Abstract][Full Text] [Related]
7. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
[TBL] [Abstract][Full Text] [Related]
8. Calcium antagonists and the kidney.
Pearce CJ; Wallin JD
New Horiz; 1996 Feb; 4(1):123-8. PubMed ID: 8689267
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus: a new agent for the prevention of graft-versus-host disease in hematopoietic stem cell transplantation.
Jacobson P; Uberti J; Davis W; Ratanatharathorn V
Bone Marrow Transplant; 1998 Aug; 22(3):217-25. PubMed ID: 9720734
[TBL] [Abstract][Full Text] [Related]
11. Nephrotoxicity of immunosuppressive drugs.
Bennett WM; Burdmann E; Andoh T; Elzinga L; Franceschini N
Miner Electrolyte Metab; 1994; 20(4):214-20. PubMed ID: 7531274
[TBL] [Abstract][Full Text] [Related]
12. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.
Barone GW; Ketel BL; Abul-Ezz SR; Lightfoot ML
JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine-A induced neurotoxicity after renal transplantation.
Derici U; Arinsoy T; Sindel S; Tali T; Leventoglu A; Sert S
Acta Neurol Belg; 2001 Jun; 101(2):124-7. PubMed ID: 11486560
[TBL] [Abstract][Full Text] [Related]
14. Renal protection with the calcium antagonists.
Neumayer HH; Kunzendorf U
J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S11-8. PubMed ID: 1723449
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of calcium antagonists on cyclosporin nephrotoxicity after clinical renal transplantation.
Morales JM; Andres A; Rodicio JL
Nephrol Dial Transplant; 1993; 8(9):880. PubMed ID: 8255527
[No Abstract] [Full Text] [Related]
16. Tacrolimus based immunosuppression.
First MR
J Nephrol; 2004; 17 Suppl 8():S25-31. PubMed ID: 15599882
[TBL] [Abstract][Full Text] [Related]
17. Overview of tacrolimus-based immunosuppression after heart or lung transplantation.
Reichenspurner H
J Heart Lung Transplant; 2005 Feb; 24(2):119-30. PubMed ID: 15701425
[TBL] [Abstract][Full Text] [Related]
18. [Controversies about the use of calcineurin inhibitors in pediatric patients].
Dello Strologo L
G Ital Nefrol; 2008; 25(3):317-24. PubMed ID: 18473303
[TBL] [Abstract][Full Text] [Related]
19. Gingival enlargement in pediatric organ transplant recipients in relation to tacrolimus-based immunosuppressive regimens.
Shiboski CH; Krishnan S; Besten PD; Golinveaux M; Kawada P; Tornabene A; Rosenthal P; Mathias R
Pediatr Dent; 2009; 31(1):38-46. PubMed ID: 19320258
[TBL] [Abstract][Full Text] [Related]
20. Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation.
Vincenti F; Rostaing L;
Contemp Clin Trials; 2005 Feb; 26(1):17-24. PubMed ID: 15837449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
